New Zealand markets closed
  • NZX 50

    11,112.16
    -28.91 (-0.26%)
     
  • NZD/USD

    0.6176
    +0.0025 (+0.41%)
     
  • ALL ORDS

    6,836.90
    +52.60 (+0.78%)
     
  • OIL

    99.03
    +0.50 (+0.51%)
     
  • GOLD

    1,743.40
    +6.90 (+0.40%)
     

Drug Device Combination Market Size Worth USD 251.90 Billion by 2030 at 7.2% CAGR - Report by Market Research Future (MRFR)

·7-min read

Drug Device Combination Market Trends and Insights by Product (catheter, antimicrobial applications, advanced wound care products), Application (coronary angioplasty, tachycardia management), End user (hospitals & clinics), Competitive Market Growth, Size, Share and Forecast to 2030

New York, USA, May 26, 2022 (GLOBE NEWSWIRE) -- Drug Device Combination Market Overview

According to a Comprehensive Research Report by Market Research Future (MRFR), “Drug Device Combination Market Information by Product, Application, End User and Region - Forecast till 2030", the market is expected to reach USD 251.90 Billion by 2030 at 7.2% CAGR.

Market Synopsis

Drug device combination devices are widely used to treat disorders such as cardiovascular diseases. The global burden of cardiovascular disease, urological disease, and others has increased in recent years. Medical devices that comprise a device and active pharmaceutical components that are chemically or physically combined as a "single-entity" are known as drug-device combination products. Due to precise medication delivery, local administration, and personalized treatment, these solutions result in safer, more effective management and treatment of various illnesses. The most common are drug-eluting stents, transdermal delivery systems, infusion pumps, inhalers, prefilled syringes, and other drug-device combo items. These cutting-edge products are being used to control and treat many chronic illnesses, including cancer, respiratory problems, cardiovascular problems, wound repair, and diabetes.

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/6946

Report Scope:

Report Attribute

Details

Market Size

USD 251.90 Billion

CAGR

7.2%

Base Year

2021

Forecast Period

2022-2030

Historical Data

2020

Forecast Units

Value (USD Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

By Product, Application, End user

Geographies Covered

North America, Europe, Asia-Pacific, and Rest of the World (RoW)

Key Market Drivers

Growing healthcare expenditure and rising awareness for the disease

Increasing R&D expenses by the key players

Drug Device Combination Market Competitive Landscape:

The central contenders in the drug device combination market are

  • C.R. BARD, Inc.

  • Cook Critical Care, Inc.

  • 3M

  • Stryker Corporation

  • Wright Medical Group, Inc.

  • Zimmer Holding, Inc

  • Abbott Laboratories

  • AlloSource

  • Biomet Orthopedics, Inc.

  • Biometrix Medical

  • Biotronik

  • Boston Scientific Corporation

  • Covidien Ltd,

  • Smith & Nephew Plc

  • St. Jude Medical Inc

Drug Device Combination Market USP Covered:

Market Drivers

The global medication device combination market is driven by rising healthcare spending, increased disease awareness, and increased R&D expenditures by crucial companies. Players in the global drug-device combination products market are projected to benefit from the development of cloud-based data management software in combination products. The rise in occurrence of chronic diseases such as cancer, diabetes, and breathing issues, as well as an increase in casualties due to accidents and trauma, a rise in the aged population, growth in the home-based healthcare market, and technical advances such as the development of prefilled syringes, are driving the global drug-device combination products market.

The accompanying benefits of lower pain intensity, better patient results, shorter hospital stays, and total healthcare cost-efficiency have all contributed to the increased acceptance of these devices. Synergistic effects that facilitate multi-target treatment, reduced tolerance levels, dose regimen simplicity, and enhanced symptomatic and pharmacokinetics are among the other benefits. These advantages are projected to drive the need for these devices and provide several potential prospects for the industry.

Drug Device Combination Market Restraints:

Conversely, the market is likely to benefit from increased healthcare infrastructure and significant market potential in underdeveloped emerging economies. Infection risk is increased by drug-device combo products, which is predicted to slow market growth. Stent infection is uncommon; however, it is associated with a high morbidity and mortality rate. Rising product recalls are likely to limit the worldwide drug-device combination products market's growth during the forecast period. Due to their antiproliferative actions, drug-eluting stents (DES) have a higher chance of infection than bare-metal stents (BMS). However, the market expansion is limited by high product prices, negative impacts, and the existence of low-income countries in emerging economies.

Drug Device Combination Market COVID 19 Analysis

The COVID-19 epidemic has had a significant impact on the private healthcare industry. During the forecast period, the worldwide drug-device combination products market is hampered by the COVID-19 pandemic. The COVID-19 epidemic and subsequent lockdowns in numerous countries around the world have impacted enterprises of all types. Furthermore, due to the COVID-19 pandemic, participants in the worldwide drug-device combination products market are experiencing severe challenges on multiple fronts. The supply of raw materials for producing medication formulations is complex because of transportation facility inconsistencies. Also, goods distributors are encountering erratic demand from retailers due to an expanding patient population dealing with COVID-19 and other life-threatening conditions.

Browse In-depth Market Research Report (90 Pages) on Drug Device Combination: https://www.marketresearchfuture.com/reports/drug-device-combination-market-6946

Drug Device Combination Market Segmentation

Based On Product

The catheter segment is estimated to gain traction in the forecast period.

Based On Application

The coronary angioplasty segment will gain significant momentum in the upcoming period.

Based On End User

In the projected term, the hospitals & clinics sector is expected to capture the largest share of the entire market. Clinics are also projected to dominate the worldwide drug-device combination market because they can detect disease and provide effective extended treatment with the help of doctors in underdeveloped countries.

Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=6946

Drug Device Combination Market Regional Insights

Due to the sheer rising number of cardiovascular disorders and key market players in the region, the Americas controlled the drug device combination market. Furthermore, favorable reimbursement rules, large healthcare expenditures, and a developed healthcare industry in the United States and Canada contribute to the market's growth. Due to well-established healthcare infrastructure, increased awareness of devices within the region, and advanced economies, Europe was expected to rank second in the global medication device combination throughout the forecast period. Furthermore, the drug device combination market benefits from a vast patient pool.

Share your Queries @ https://www.marketresearchfuture.com/enquiry/6946

The Asia-Pacific area was predicted to be the quickest expanding. This is attributable to increased market penetration by regional market participants, a developing healthcare sector, and increased government backing for international investments. The Middle East and Africa, on the other hand, had the smallest share of the global drug device combination market due to underdeveloped economies and low per capita income, particularly in Africa. The Middle Eastern region is expected to be a significant market for the Middle East and Africa.

Discover more research Reports on Healthcare Industry, by Market Research Future:

Breast Implants Market Trends, Growth and Size Analysis By Product (Silicone implants, Saline implants, Smooth Breast implants, Round implants), Shape (Anatomical, Round), Application (Breast Reconstruction, Breast Augmentation), End-User (Clinics) -Forecast Till 2027

Cardiac Monitoring and Cardiac Rhythm Management Device Market, by Cardiac Device (Pacemaker and Others), by Cardiac Monitoring (Electrocardiogram), by CRM (Defibrillators and Others), by End-User (Hospitals and Others)–Global Forecast Till 2027

Cerebral Palsy Market Research Report: By Type (Spastic Cerebral Palsy, Dyskinetic Cerebral Palsy, Hypotonic Cerebral Palsy, Ataxic Cerebral Palsy, Other), by Diagnosis (Imaging Tests, Others), by Treatment (Therapy, Medication, Other)- Forecast Till 2027

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter

CONTACT: Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting